Press Contact
For media enquiries, please reach out to: contact@aspivix.com
All
- All
- Blog
- In the media
- Press releases
Aspivix Achieves New Milestone: Study Results Peer-Reviewed and Published in the International Journal of Gynecology & Obstetrics
A multicenter post-marketing study reveals safety and efficacy of carevix® in gynecological IUD insertion procedures LOS ANGELES, Feb. 5, 2026 — Aspivix - a FemTech company dedicated to modernizing gynecological care - announced the...
Leading the Way in Women’s Health Innovation
💡 Celebrating Women in MedTech: Ikram Guerd 💡 Thank you to Women of Wearables (WoW) for spotlighting the work we are doing at Aspivix and our GM U.S. & CMO, Ikram Guerd....
An unsung hero in Femtech
Behind every breakthrough in women’s health, there are innovators working quietly, relentlessly, and with purpose. We’re proud to spotlight our CTO and co-founder, Julien Finci, an engineer who helped challenge a century-old...
“Must IUD insertion really be this painful?”
This question is now being asked openly — and rightfully so — in a newly published article addressing pain during IUD insertion. At Aspivix, this question has guided our work from day...
New Scientific Publication in the International Journal of Gynecology & Obstetrics
We are proud to share an important milestone for Aspivix and for carevix®, marking a significant step forward in evidence-based innovation in women’s health. The results of our Ambassador Program have now...
Real stories, real change in women’s health
Meet Maud (27), the first patient in the Netherlands to share her experience of getting an IUD placed with carevix®. In her own words:“It really makes a big difference… the placement was...
